Related Experiment Videos
Use of pharmacokinetic-pharmacodynamic relationships in the development of new anthracyclines
1Fondation Bergonié, Bordeaux, France.
Cancer Chemotherapy and Pharmacology
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin.
British journal of cancer·1999
A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in France.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·1999
Thoracic outlet syndrome: influence of personal history and surgical technique on long-term results.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·1999
Beneficial effects of leukocyte-depleted blood and low-potassium dextran solutions on microvascular permeability in preserved porcine lung.
American journal of respiratory and critical care medicine·1999
Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.
American journal of respiratory and critical care medicine·1999
Pharmacological targeting of xCT/system Xc- to modulate temozolomide sensitivity in glioma and glioblastoma preclinical models: a focused systematic review.
Cancer chemotherapy and pharmacology·2026
Beyond gastric acid: pharmacologic modulation of the tumor microenvironment by vonoprazan and its drug-interaction implications for chemotherapy and immunotherapy.
Cancer chemotherapy and pharmacology·2026
Risk factors for immune-related adverse events associated with pembrolizumab in patients with solid tumors.
Cancer chemotherapy and pharmacology·2026
PROTACs in personalized and precision medicine: transforming targeted therapy with advances in selectivity and patient stratification.
Cancer chemotherapy and pharmacology·2026
Continuous infusion of granulocyte colony-stimulating factor is associated with an advantage in neutrophil recovery in pediatric oncologic disorders.
Cancer chemotherapy and pharmacology·2026
Population pharmacokinetic analysis of pirtobrutinib, a non-covalent BTK inhibitor, in patients with hematological malignancies from the Phase 1/2 BRUIN study.
Cancer chemotherapy and pharmacology·2026